GlycoMimetics (GLYC)
(Real Time Quote from BATS)
$0.26 USD
0.00 (-0.92%)
Updated May 14, 2024 10:22 AM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Brokerage Reports
GlycoMimetics, Inc. [GLYC]
Reports for Purchase
Showing records 141 - 157 ( 157 total )
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Future AML Label Breadth Manifesting; Reiterating Buy - Raising PT to $35
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
The Brave New World of AML
Provider: Roth Capital Partners, Inc.
Company: GlycoMimetics, Inc.
Industry: Medical - Drugs
Through the AML Looking-Glass; Initiating with Buy and $25 PT
Provider: Roth Capital Partners, Inc.